Recombinant human erythropoietin for patients with AIDS treated with zidovudine

New England Journal of Medicine

Volumn 322, Issue 21, 1990, Pages 1488-1493

  Fischl, Margaret ^a   Galpin, Jeffrey E ^b   Levine, James D ^c   Groopman, Jerome E ^c   Henry, David H ^d   Kennedy, Peter ^e   Miles, Steven ^f   Robbins, William ^g   Starrett, Barbara ^h   Zalusky, Ralph ⁱ   Abels, Robert I ^j   Tsai, Huei C ^j   Rudnick, Seth A ^j  

^a UNIVERSITY OF MIAMI   (United States)

^b Porton Medical Group ^*  (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d GRADUATE HOSPITAL   (United States)

^e Los Angeles Oncologic Institute   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g Community Research Initiatives ^*  (United States)

^h Beth Israel Medical Center ^*  (United States)

ⁱ BETH ISRAEL MEDICAL CENTER   (United States)

^j Ortho McNeil Pharmaceutical Incorporated   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANEMIA; ARTICLE; BONE MARROW SUPPRESSION; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANEMIA; BLOOD TRANSFUSION; BONE MARROW; DOUBLE-BLIND METHOD; ERYTHROPOIETIN; FEMALE; HEMATOCRIT; HUMAN; MALE; MIDDLE AGE; RANDOMIZED CONTROLLED TRIALS; RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T; ZIDOVUDINE;

EID: 0025300493     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199005243222103     Document Type: Article

References (12)

1. Fischl MA, Richman DD, Grieco MH, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. N Engl J Med 1987; 317: 185–91.
2. Richman DD, Fischl MA, Grieco MH, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. N Engl J Med 1987; 317: 192–7.
3. Report of the Workgroup on Epidemiology and Surveillance: background and progress since Coolfont. Public Health Rep 1988; 103: Suppl 1: 10–1.
4. Cumming PD, Schorr JB, Wallace EL. Annual blood facts: United States totals 1986/87. Washington, D.C.: American Red Cross, 1988.
5. Wu HS, Little AG. Perioperative blood transfusions and cancer recurrence. J Clin Oncol 1988; 6: 1348–54.
6. Stephenson KR, Steinberg SM, Hughes KS, Vetto JT, Sugarbaker PH, Chang AE. Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastases. Ann Surg 1988; 208: 679–87.
7. Kahan BD. Effects of transfusion on recipient immune status: relationship to transplantation. In: Dodd RY, Barker LF, eds. Infection, immunity, and blood transfusion. Vol. 182 of Progress in clinical and biological research. New York: Alan R. Liss, 1985:345–74.
8. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207–14.
9. Winer BJ. Statistical principles in experimental design. New York: McGraw-Hill, 1971:752–812.
10. SAS user's guide: statistics. Cary, N.C.: SAS Institute, 1985.
11. Spivak JL, Barnes DC, Fuchs E, Quinn TC. Serum immunoreactive erythropoietin in HIV-infected patients. JAMA 1989; 261: 3104–7.
12. Dournon D, Matheron S, Rozenbaum W, et al. Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex. Lancet 1988; 2: 1297–302.